Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 9/20 | 0.50 |
| ▸ | MMP8 | P22894 | 4/20 | 0.50 |
| ▸ | MMP2 | P08253 | 12/20 | 0.49 |
| ▸ | MMP3 | P08254 | 6/20 | 0.49 |
| ▸ | FCER2 | P06734 | 2/20 | 0.48 |
| ▸ | MME | P08473 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 3/20 | 0.47 |
| ▸ | MMP7 | P09237 | 2/20 | 0.47 |
| ▸ | LTA4H | P09960 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29311759 | 0.89 | ALDH1A1 (0.51) | MMP1MMP8MMP2MMP3FCER2 | |
| SCHEMBL29311610 | 0.89 | MME (0.47) | MMP1MMP8MMP2MMP3FCER2 | |
| SCHEMBL27271192 | 0.88 | MMP2 (0.47) | MMP1MMP8MMP2MMP3MME | |
| SCHEMBL29311795 | 0.87 | MMP1 (0.52) | MMP1MMP8MMP2MMP3FCER2 | |
| SCHEMBL13402948 | 0.86 | MMP1 (0.51) | MMP1MMP8MMP2MMP3FCER2 | |
| SCHEMBL27267988 | 0.85 | NPC1 (0.56) | MMP1MMP8MMP2MMELTA4H | |
| SCHEMBL25380959 | 0.85 | MME (0.60) | MMP2MMEMMP9MMP7LTA4H | |
| SCHEMBL9181909 | 0.85 | MME (0.60) | MMP2MMEMMP9MMP7LTA4H | |
| SCHEMBL29311875 | 0.83 | ATM (0.48) | MMP1MMP8MMEMMP9 | |
| SCHEMBL23306955 | 0.83 | MME (0.53) | MMP1MMP8MMEMMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | Quantum-Si Incorporated (US) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | VIP, DNPEP, PREP | MMP1 262/4885MMP8 378/4885MMP2 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.